About the Authors
- Hideyuki Matsumoto
-
* E-mail: hideyukimatsumoto.jp@gmail.com
Affiliation Department of Neurology, University of Tokyo, Tokyo, Japan
- Yasuo Terao
-
Affiliation Department of Neurology, University of Tokyo, Tokyo, Japan
- Akihiro Yugeta
-
Affiliation Department of Neurology, University of Tokyo, Tokyo, Japan
- Hideki Fukuda
-
Affiliation Segawa Neurological Clinic for Children, Tokyo, Japan
- Masaki Emoto
-
Affiliation Interfaculty Initiative in Information Studies, University of Tokyo, Tokyo, Japan
- Toshiaki Furubayashi
-
Affiliation Department of Neurology, School of Medicine, Fukushima Medical University, Fukushima, Japan
- Tomoko Okano
-
Affiliation Department of Neurology, University of Tokyo, Tokyo, Japan
- Ritsuko Hanajima
-
Affiliation Department of Neurology, University of Tokyo, Tokyo, Japan
- Yoshikazu Ugawa
-
Affiliation Department of Neurology, School of Medicine, Fukushima Medical University, Fukushima, Japan
Competing Interests
The authors received funding from a commercial source (GlaxoSmithKline, Boehringer Ingelheim, Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd.). Dr. Terao is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received speaker's honoraria from Boehringer Ingelheim. Dr. Hanajima is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and has received speaker's honoraria from Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd. Dr. Ugawa is supported by supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; by grants for the Research Committee on the Best rTMS Treatment of Parkinson's Disease from the Ministry of Health and Welfare of Japan; by the Research Committee on Dystonia of the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: HM YT YU. Performed the experiments: HM YT AY HF ME TF TO. Analyzed the data: HM YT RH YU. Contributed reagents/materials/analysis tools: YT HF RH YU. Wrote the paper: HM YT RH YU.